AAV-Mediated Knock-Down of HRC Exacerbates Transverse Aorta Constriction-Induced Heart Failure

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Park, Chang Sik ^a   Cha, Hyeseon ^a   Kwon, Eun Jeong ^a   Jeong, Dongtak ^b   Hajjar, Roger J ^b   Kranias, Evangelia G ^c   Cho, Chunghee ^a   Park, Woo Jin ^a   Kim, Do Han ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; CALCIUM BINDING PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CALSEQUESTRIN; CASPASE 3; HISTIDINE RICH CALCIUM BINDING PROTEIN; LYSOPHOSPHOLIPASE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SMALL INTERFERING RNA; SODIUM CALCIUM EXCHANGE PROTEIN; TRIADIN; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CALCIUM TRANSPORT; CELL DEATH; CONTROLLED STUDY; CONVALESCENCE; CYTOSOL; DISEASE EXACERBATION; DISEASE MODEL; DOWN REGULATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; GENE SILENCING; HEART FAILURE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HUMAN; HUMAN CELL; MALE; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; RNA INTERFERENCE; UPREGULATION;

ANIMALS; AORTA; CALCIUM; CALCIUM-BINDING PROTEINS; CARDIOMEGALY; CARRIER PROTEINS; CONSTRICTION; CYTOSOL; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; GENE EXPRESSION REGULATION; HEART; HEART FAILURE; HISTIDINE; HOMEOSTASIS; ISOPROTERENOL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE PROTEINS; PHENOTYPE; PHOSPHORYLATION; RNA, SMALL INTERFERING; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

ADENO-ASSOCIATED VIRUS; RATTUS;

EID: 84865472735     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043282     Document Type: Article

References (50)

1. Hofmann SL, Goldstein JL, Orth K, Moomaw CR, Slaughter CA, et al. (1989) Molecular cloning of a histidine-rich Ca2+-binding protein of sarcoplasmic reticulum that contains highly conserved repeated elements. J Biol Chem 264: 18083-18090.
2. Picello E, Damiani E, Margreth A, (1992) Low-affinity Ca2+-binding sites versus Zn2+-binding sites in histidine-rich Ca2+-binding protein of skeletal muscle sarcoplasmic reticulum. Biochem Biophys Res Commun 186: 659-667.
3. Suk JY, Kim YS, Park WJ, (1999) HRC (histidine-rich Ca2+ binding protein) resides in the lumen of sarcoplasmic reticulum as a multimer. Biochem Biophys Res Commun 263: 667-671.
4. Lee HG, Kang H, Kim DH, Park WJ, (2001) Interaction of HRC (histidine-rich Ca2+-binding protein) and triadin in the lumen of sarcoplasmic reticulum. J Biol Chem 276: 39533-39538.
5. Kobayashi YM, Alseikhan BA, Jones LR, (2000) Localization and characterization of the calsequestrin-binding domain of triadin 1. Evidence for a charged beta-strand in mediating the protein-protein interaction. J Biol Chem 275: 17639-17646.
6. Guo W, Campbell KP, (1995) Association of triadin with the ryanodine receptor and calsequestrin in the lumen of the sarcoplasmic reticulum. J Biol Chem 270: 9027-9030.
7. Lee JM, Rho SH, Shin DW, Cho C, Park WJ, et al. (2004) Negatively charged amino acids within the intraluminal loop of ryanodine receptor are involved in the interaction with triadin. J Biol Chem 279: 6994-7000.
8. Arvanitis DA, Vafiadaki E, Fan GC, Mitton BA, Gregory KN, et al. (2007) Histidine-rich Ca2+-binding protein interacts with sarcoplasmic reticulum Ca2+-ATPase. Am J Physiol Heart Circ Physiol 293: H1581-1589.
9. Kim E, Shin DW, Hong CS, Jeong D, Kim DH, et al. (2003) Increased Ca2+ storage capacity in the sarcoplasmic reticulum by overexpression of HRC (histidine-rich Ca2+ binding protein). Biochem Biophys Res Commun 300: 192-196.
10. Fan GC, Gregory KN, Zhao W, Park WJ, Kranias EG, (2004) Regulation of myocardial function by histidine-rich, calcium-binding protein. Am J Physiol Heart Circ Physiol 287: H1705-1711.
11. Gregory KN, Ginsburg KS, Bodi I, Hahn H, Marreez YM, et al. (2006) Histidine-rich Ca2+ binding protein: a regulator of sarcoplasmic reticulum calcium sequestration and cardiac function. J Mol Cell Cardiol 40: 653-665.
12. Jaehnig EJ, Heidt AB, Greene SB, Cornelissen I, Black BL, (2006) Increased susceptibility to isoproterenol-induced cardiac hypertrophy and impaired weight gain in mice lacking the histidine-rich calcium-binding protein. Mol Cell Biol 26: 9315-9326.
13. Zhao X, Min CK, Ko JK, Parness J, Kim DH, et al. (2010) Increased store-operated Ca2+ entry in skeletal muscle with reduced calsequestrin-1 expression. Biophys J 99: 1556-1564.
14. Gyorke I, Hester N, Jones LR, Gyorke S, (2004) The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J 86: 2121-2128.
15. Terentyev D, Cala SE, Houle TD, Viatchenko-Karpinski S, Gyorke I, et al. (2005) Triadin overexpression stimulates excitation-contraction coupling and increases predisposition to cellular arrhythmia in cardiac myocytes. Circ Res 96: 651-658.
16. Chopra N, Yang T, Asghari P, Moore ED, Huke S, et al. (2009) Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias. Proc Natl Acad Sci U S A 106: 7636-7641.
17. Du GG, Guo X, Khanna VK, MacLennan DH, (2001) Ryanodine sensitizes the cardiac Ca2+ release channel (ryanodine receptor isoform 2) to Ca2+ activation and dissociates as the channel is closed by Ca2+ depletion. Proc Natl Acad Sci U S A 98: 13625-13630.
18. Jiang D, Xiao B, Zhang L, Chen SR, (2002) Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death. Circ Res 91: 218-225.
19. Lennart S, Henry F, Elie C, Stefanie K, Lahouaria H, et al. (2009) Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy. Circulation 119: 1241-1252.
20. Diez J, Fortuno MA, Ravassa S, (1998) Apoptosis in hypertensive heart disease. Curr Opin Cardiol 13: 317-325.
21. Hang T, Huang Z, Jiang S, Gong J, Wang C, et al. (2006) Apoptosis in pressure overload-induced cardiac hypertrophy is mediated, in part, by adenine nucleotide translocator-1. Ann Clin Lab Sci 36: 88-95.
22. Zhu W, Woo AY, Yang D, Cheng H, Crow MT, et al. (2007) Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J Biol Chem 282: 10833-10839.
23. Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM, (2005) Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res 97: 1314-1322.
24. Zhang T, Maier LS, Dalton ND, Miyamoto S, Ross J Jr, et al. (2003) The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res 92: 912-919.
25. Zhang T, Kohlhaas M, Backs J, Mishra S, Phillips W, et al. (2007) CaMKIIdelta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses. J Biol Chem 282: 35078-35087.
26. Ling H, Zhang T, Pereira L, Means CK, Cheng H, et al. (2009) Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J Clin Invest 119: 1230-1240.
27. Wehrens XH, Lehnart SE, Reiken SR, Marks AR, (2004) Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ Res 94: e61-70.
28. Guo T, Zhang T, Mestril R, Bers DM, (2006) Ca2+/Calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes. Circ Res 99: 398-406.
29. Zhang T, Brown JH, (2004) Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc Res 63: 476-486.
30. Palomeque J, Rueda OV, Sapia L, Valverde CA, Salas M, et al. (2009) Angiotensin II-induced oxidative stress resets the Ca2+ dependence of Ca2+-calmodulin protein kinase II and promotes a death pathway conserved across different species. Circ Res 105: 1204-1212.
31. Baines CP, Molkentin JD, (2005) STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol 38: 47-62.
32. Zhou X, Fan GC, Ren X, Waggoner JR, Gregory KN, et al. (2007) Overexpression of histidine-rich Ca2+-binding protein protects against ischemia/reperfusion-induced cardiac injury. Cardiovasc Res 75: 487-497.
33. Hoch B, Meyer R, Hetzer R, Krause EG, Karczewski P, (1999) Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ Res 84: 713-721.
34. Zhang T, Johnson EN, Gu Y, Morissette MR, Sah VP, et al. (2002) The cardiac-specific nuclear delta(B) isoform of Ca2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J Biol Chem 277: 1261-1267.
35. Nguyen A, Chen P, Cai H, (2004) Role of CaMKII in hydrogen peroxide activation of ERK1/2, p38 MAPK, HSP27 and actin reorganization in endothelial cells. FEBS Lett 572: 307-313.
36. Arvanitis DA, Sanoudou D, Kolokathis F, Vafiadaki E, Papalouka V, et al. (2008) The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy. Eur Heart J 29: 2514-2525.
37. Han P, Cai W, Wang Y, Lam CK, Arvanitis DA, et al. (2011) Catecholaminergic-induced arrhythmias in failing cardiomyocytes associated with human HRCS96A variant overexpression. Am J Physiol Heart Circ Physiol 301: H1588-1595.
38. Claycomb WC, Lanson NA Jr, Stallworth BS, Egeland DB, Delcarpio JB, et al. (1998) HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A. 95: 2979-84.
39. Dongtak J, Hyeseon C, Eunyoung K, Misuk K, Dong KY, et al. (2006) PICOT inhibits cardiac hypertrophy and enhances ventricular function and cardiomyocyte contractility. Circ Res 99: 307-314.
40. Sahoo SK, Kim T, Kang GB, Lee JG, Eom SH, et al. (2009) Characterization of calumenin-SERCA2 interaction in mouse cardiac sarcoplasmic reticulum. J Biol Chem 284: 31109-31121.
41. Chen SR, Vaughan DM, Airey JA, Coronado R, MacLennan DH, (1993) Functional expression of cDNA encoding the Ca2+ release channel (ryanodine receptor) of rabbit skeletal muscle sarcoplasmic reticulum in COS-1 cells. Biochemistry 32: 3743-3753.
42. Kim DH, Mkparu F, Kim CR, Caroll RF, (1994) Alteration of Ca2+ release channel function in sarcoplasmic reticulum of pressure-overload-induced hypertrophic rat heart. J Mol Cell Cardiol 26: 1505-1512.
43. Seo IR, Moh SH, Lee EH, Meissner G, Kim DH, (2006) Aldolase potentiates DIDS activation of the ryanodine receptor in rabbit skeletal sarcoplasmic reticulum. Biochem J 399: 325-333.
44. Babu GJ, Bhupathy P, Petrashevskaya NN, Wang H, Raman S, et al. (2006) Targeted overexpression of sarcolipin in the mouse heart decreases sarcoplasmic reticulum calcium transport and cardiac contractility. J Biol Chem 281: 3972-3979.
45. Ward P, Linden RM, (2000) A role for single-stranded templates in cell-free adeno-associated virus DNA replication. J Virol 74: 744-754.
46. Linden RM, (2002) Gene therapy gets the Beauty treatment. Nat Biotechnol 20: 987-988.
47. Ward P, Elias P, Linden RM, (2003) Rescue of the adeno-associated virus genome from a plasmid vector: evidence for rescue by replication. J Virol 77: 11480-11490.
48. Cha H, Jeong HJ, Jang SP, Kim JY, Yang DK, et al. (2010) Parathyroid hormone accelerates decompensation following left ventricular hypertrophy. Exp Mol Med 42: 61-68.
49. Pyoung OY, Min-Ah L, Hyeseon C, Moon HJ, Jooyeon K, et al. (2010) The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis. J Mol Cell Cardiol 49: 294-303.
50. Seunghee Lee, Jooyeon K, Joo YR, Suho L, Dong KY, et al. (2012) Transcription coactivator Eya2 is a critical regulator of physiological hypertrophy. J Mol Cell Cardiol 52: 718-726.